These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5010762)

  • 21. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mydocalm administered in electrophoresis].
    Chmielewski F
    Pol Tyg Lek; 1971 Jul; 26(30):1170-2. PubMed ID: 5092988
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of thrombo-obliterative diseases of the lower extremity arteries using acetylcholine].
    Moskalenko VS
    Klin Khir (1962); 1972 May; 5():71-2. PubMed ID: 5043908
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of peripheral ischemizing arteriopathies with diisopropylammonium dichloroethanoate (Diedì), a drug with action prevalent on respiratory tissue metabolism].
    Maggi GC; Tartara A
    Minerva Cardioangiol; 1965 Jul; 13(7):382-3. PubMed ID: 5838538
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemosorption in the treatment of occlusive arterial diseases of the legs].
    Korneev AA; Petukhov EB; Rodionov SV
    Vestn Khir Im I I Grek; 1988 Jul; 141(7):60-2. PubMed ID: 3222899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1977 Apr; 1(6066):933-4. PubMed ID: 856391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
    Stepanova-Nikitina GG; Rage KM
    Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.
    Chakrabarti R
    Acta Univ Carol Med Monogr; 1972; 53():261-2. PubMed ID: 4670736
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic occlusive arterial disease of the lower extremities.
    deWolfe VG
    Cardiovasc Clin; 1983; 13(2):15-35. PubMed ID: 6839320
    [No Abstract]   [Full Text] [Related]  

  • 34. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R; Bielawiec M; Kiersnowska B; Lukjan H; Perzanowski A; Mysliwiec M; Korfel B; Rogowski F
    Z Gesamte Inn Med; 1976 Dec; 31(24):1025-7. PubMed ID: 1020408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombolytic treatment of chronic arterial obstruction].
    Mazák J; Bláha M; Vodicková L; Pidrman V
    Vnitr Lek; 1974 Jul; 20(6):596-602. PubMed ID: 4844794
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperproduction of immunoglobulin E in occlusive diseases of the peripheral arteries].
    Baranov AA; Shilkina NP; Masenko VP; Kushekbaeva AE; Nasonov EL; Lebedin IuG
    Klin Med (Mosk); 1991 Apr; 69(4):45-8. PubMed ID: 1865650
    [No Abstract]   [Full Text] [Related]  

  • 38. [Specific features of carbohydrate metabolism in tissue of the extremities in obliterative disorders of peripheral arteries].
    Korotkina RN; Nosova IM; Zolotorevskiĭ VIa
    Klin Med (Mosk); 1979 Jan; 57(1):47-52. PubMed ID: 439799
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of occlusive diseases of the arteries in the limbs with pyridinol-carbamate.
    Matsumoto K; Sato K; Tanaka S
    Jpn Heart J; 1966 Jan; 7(1):87-93. PubMed ID: 5295647
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.